Skip to main content

Revelation Biosciences, Inc.

REVBW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001810560

No open-market purchases or sales by Revelation Biosciences, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $9.99K in total; no superinvestor holds it.

Other share classesREVB

Superinvestors holding REVBW, Q2 2026

See all superinvestors

No superinvestor reported holding REVBW in Q2 2026.